Notice of Submittal of Proposed Rule to
Legislative Council Rules Clearinghouse
On November 13, 2020 the Controlled Substances Board submitted a proposed rule to the Wisconsin Legislative Council Clearinghouse pursuant to s. 227.15 (1), Wis. Stats. Analysis
The proposed rules affect Chapter CSB 4, relating to designating Gabapentin as a monitored drug.
Statement of Scope
The scope statement for this rule, SS 111-19, was approved by the Governor on October 3, 2019, published in Register No. 767A1, on November 4, 2019, and approved by the Controlled Substances Board on November 26, 2019. Agency Procedure for Promulgation
A public hearing is required and will be held on January 15, 2021.
Agency Organizational Unit Primarily Responsible for Promulgating Rule
Controlled Substances Board
Agency Contact Person
